Laws
Treaties
Judgments
Browse By Jurisdiction
Federal Act of December 15, 2000, on Medicinal Products and Medical Devices (status as of October 1, 2010), Switzerland
Back
Superseded Text
Go to latest Version in WIPO Lex
Year of Version
2010
Dates
Entry into force:
January 1, 2002
Adopted:
December 15, 2000
Type of Text
IP-related Laws
Subject Matter
Patents (Inventions),
Undisclosed Information (Trade Secrets),
Enforcement of IP and Related Laws,
Other
Notes
The notification by Switzerland to the WTO under Article 63.2 of TRIPS states:
Article 12 grants the protection to the first applicant seeking marketing authorization for medicinal products. Pursuant to Art. 39.3 of the TRIPS Agreement, Article 12. 2 ensures a ten year data exclusivity period for medical products to the first applicant (the holder of the original market approval).
Article 14.3 provides an exclusion from the simplified market authorization procedure for as long as the original preparation is protected by patent.
Articles 61 to 64 concern the undisclosed information including trade secrets and test data related to medicines.'
Available Texts
Main text(s)
Main text(s)
French
Loi fédérale du 15 décembre 2000 sur les médicaments et les dispositifs médicaux (état le 1er octobre 2010)
PDF
HTML
German
Bundesgesetz vom 15. Dezember 2000 über Arzneimittel und Medizinprodukte (stand am 1. Oktober 2010)
PDF
HTML
Legislation
Supersedes (2 text(s))
Supersedes (2 text(s))
Is superseded by (5 text(s))
Is superseded by (5 text(s))
WIPO Lex No.
CH244